Personal information

Emails & domains

Verified email addresses

Keywords

Molecular Biology, Cholangiocarcinoma, Pancreatic Ductal Adenocarcinoma, Biomarkers, MicroRNAs

Countries

Brazil

Biography

Master's student in Health Sciences of the Faculty of Medicine of São José do Rio Preto (FAMERP). Graduated in Biomedicine from Paulista University (2021) with scholarship from University for All Program (PROUNI). Electronics Technician from SENAI - Antonio Devisate from São José do Rio Preto (2016). Scientific Initiation with a scholarship from the The São Paulo Research Foundation (FAPESP). He has experience in Molecular Biology: Molecular, Genetic and Biochemical Markers in Biliopancreatic Diseases. He is also a collaborating researcher at the Research Center in Biochemistry and Molecular Biology (NPBIM) at FAMERP.

Activities

Collapse all

Education and qualifications (3)

Faculdade de Medicina de São José do Rio Preto: São José do Rio Preto, São Paulo, BR

2022-03-01 to present | Master's degree (Biochemistry and Molecular Biology Research Center (NPBIM/FAMERP))
Qualification
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

Universidade Paulista Campus de São José do Rio Preto: Sao Jose do Rio Preto, SP, BR

2018-02-03 to 2021-12-31 | Biomedicine
Education
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

National Service of Industrial Training (SENAI): São José do Rio Preto, São Paulo, BR

2015-02-01 to 2016-12-24 | Electronics Technician (São Paulo Regional Department)
Education
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

Professional activities (3)

Faculty of Medicine of São José do Rio Preto (FAMERP): São José do Rio Preto, São Paulo, BR

2020-08 to present | Collaborating researcher (Research Center in Biochemistry and Molecular Biology (NPBIM))
Membership
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

Japan Foundation/Japan Educational Exchanges and Services (JEES): Tokyo, JP

2022-01-13 | Japanese-Language Proficiency Test N5 (JLPT/日本語能力試験)
Distinction
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

Faculty of Medicine of São José do Rio Preto (FAMERP): São José do Rio Preto, São Paulo, BR

2021-06-01 to 2021-12-31 | Scientific Research/ Scholarship (FAPESP: 2021/02964-3) (Biochemistry and Molecular Biology Research Center (NPBIM/FAMERP))
Service
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

Funding (1)

Expression of miR-145-3p Associated with Clinical and Prognostic Characteristics in Cholangiocarcinoma

2021-06 to 2021-12 | Grant
São Paulo Research Foundation (FAPESP) (São Paulo, São Paulo, BR)
GRANT_NUMBER:

2021/02964-3
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

Works (30)

Immunohistochemical Analysis of Inter-Alpha-Trypsin Inhibitor Heavy Chain 2 and Enolase 1 in Canine Mammary Tumors: Associations with Tumor Aggressiveness and Prognostic Significance

Veterinary Sciences
2025-02 | Journal article | Author
DOI: 10.3390/vetsci12020110
Contributors: LUADNA DOS SANTOS E SILVA; Pedro Henrique Fogaça Jordão; Beatriz Castilho Balieiro; Laura de Souza Baracioli; Daniela Farias de Nóbrega; Adriana Alonso Novais; Chuffa LG; Debora Aparecida Pires de Campos Zuccari
Source: check_circle
Multidisciplinary Digital Publishing Institute

MicroRNAs Associated with Cholangiocarcinoma and its Relationship with Radiotherapy with Iodine-131 in an in vitro Model

67th Brazilian Congress of Genetics
2022-09-15 | Conference poster
Contributors: Pedro Henrique Fogaça Jordão
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

Genes associated with angiogenesis may be regulated by metabolic radiotherapy on cholangiocarcinoma cells

ESMO 24th World Congress on Gastrointestinal Cancer 2022
2022-06 | Conference poster
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

miR-145-3p subexpression, life habits and comorbidities in cholangiocarcinoma carcinogenesis pathway

ESMO 24th World Congress on Gastrointestinal Cancer 2022
2022-06 | Conference poster
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

Overexpression of mir-224-3p in extrahepatic cholangiocarcinoma associated with increased dose of I131 radiotherapy: An in vitro study

ESMO 24th World Congress on Gastrointestinal Cancer 2022
2022-06 | Conference poster
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

P-104 Overexpression of mir-224-3p in extrahepatic cholangiocarcinoma associated with increased dose of I131 radiotherapy: An in vitro study

Annals of Oncology
2022-06 | Conference abstract
DOI: 10.1016/j.annonc.2022.04.194
Part of ISSN: 0923-7534
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

P-105 miR-145-3p subexpression, life habits and comorbidities in cholangiocarcinoma carcinogenesis pathway

Annals of Oncology
2022-06 | Conference abstract
DOI: 10.1016/j.annonc.2022.04.195
Part of ISSN: 0923-7534
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

P-284 Genes associated with angiogenesis may be regulated by metabolic radiotherapy on cholangiocarcinoma cells

Annals of Oncology
2022-06 | Conference abstract
DOI: 10.1016/j.annonc.2022.04.373
Part of ISSN: 0923-7534
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

Analysis of hsa-miR-145-3p expression, lifestyle habits and comorbidities in patients with cholangiocarcinoma

GENÉTICA 2021 - 66th Brazilian Congress of Genetics
2021 | Conference poster
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

Cholangiocarcinoma: Tumor Suppressor miR-101-3p As Potential Diagnosis And Prognostic Biomarker

ALAG 2021 - XVIII Latin American Congress of Genetics
2021 | Conference abstract
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

Expression of HIF-1a and miRNAs Involved in Carcinogenesis in Patients with Cholangiocarcinoma

XVIII CAIC – Annual Congress of Scientific Initiation and VI Scientific Congress FAMERP/FUNFARME
2021 | Conference poster
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

Expression of HIF-1a and miRNAs Involved in Carcinogenesis in Patients with Cholangiocarcinoma

XVIII CAIC – Annual Congress of Scientific Initiation and VI Scientific Congress FAMERP/FUNFARME
2021 | Conference abstract
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

Expression Of Tumor Suppressor miR-142-3p Is Reduced In Patients With Cholangiocarcinoma

ALAG 2021 - XVIII Latin American Congress of Genetics
2021 | Conference abstract
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

Gene and protein overexpression of PTEN in cholangiocarcinoma: a possible diagnostic marker

HEPATO 2021 - XXVI Brazilian Congress of Hepatology
2021 | Conference abstract
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

High dose 131I radiotherapy in extrahepatic cholangiocarcinoma cell line associated with hsa- miR-224-3p overexpression

GENÉTICA 2021 - 66th Brazilian Congress of Genetics
2021 | Conference poster
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

In vitro Iodine-131 Radiotherapy Induces Underexpression of Angiogenesis-Associated Genes in Cholangiocarcinoma: A Potential Therapeutic Approach

HEPATO 2021 - XXVI Brazilian Congress of Hepatology
2021 | Conference abstract
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

Iodine-131 Metabolic Radiotherapy in vitro Leads to HIF-1a and VEGF-A Undexpression on Cholangiocarcinoma

GENÉTICA 2021 - 66th Brazilian Congress of Genetics
2021 | Conference poster
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

Iodine-131 Metabolic Radiotherapy Leads To Angiogenesis Genes Underxpression On Cholangiocarcinoma Cells

ALAG 2021 - XVIII Latin American Congress of Genetics
2021 | Conference poster
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

Iodine‑131 Metabolic Radiotherapy Leads To Angiogenesis Genes Underexpression On Cholangiocarcinoma Cells

ALAG 2021 - XVIII Latin American Congress of Genetics
2021 | Conference abstract
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

MicroRNAs involved in oncogenesis in patients with cholangiocarcinoma and the relationship with radiotherapy with iodine-131 in an in vitro model

HEPATO 2021 - XXVI Brazilian Congress of Hepatology
2021 | Conference abstract
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

miR-224-3p Overexpression Is Associated With Increased Dose Of I131 Radiotherapy In Extrahepatic CCA Cells

ALAG 2021 - XVIII Latin American Congress of Genetics
2021 | Conference poster
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

miR-224-3p Overexpression Is Associated With Increased Dose Of I131 Radiotherapy In Extrahepatic CCA Cells

ALAG 2021 - XVIII Latin American Congress of Genetics
2021 | Conference abstract
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

Overexpression of miR-145-3p and Lifestyles Associated with Cholangiocarcinoma

HEPATO 2021 - XXVI Brazilian Congress of Hepatology
2021 | Conference abstract
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

Overexpression of oncomiR miR-21-3p Related to Cholangiocarcinoma Patients

HEPATO 2021 - XXVI Brazilian Congress of Hepatology
2021 | Conference poster
Contributors: Pedro Henrique Fogaça Jordão
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

Overexpression of oncomiR miR-21-3p Related to Cholangiocarcinoma Patients

HEPATO 2021 - XXVI Brazilian Congress of Hepatology
2021 | Conference abstract
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

Tumor Suppressor miR-101-3p Related To Patients With Cholangiocarcinoma

GENÉTICA 2021 - 66th Brazilian Congress of Genetics
2021 | Conference poster
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

Tumor suppressor miR-145-3p underexpression in patients with cholangiocarcinoma

XVIII CAIC – Annual Congress of Scientific Initiation and VI Scientific Congress FAMERP/FUNFARME
2021 | Conference poster
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

Tumor suppressor miR-145-3p underexpression in patients with cholangiocarcinoma

XVIII CAIC – Annual Congress of Scientific Initiation and VI Scientific Congress FAMERP/FUNFARME
2021 | Conference abstract
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

Underexpression Of The Tumor Suppressor miR-145 In Patients With Cholangiocarcinoma

ALAG 2021 - XVIII Latin American Congress of Genetics
2021 | Conference abstract
Source: Self-asserted source
Pedro Henrique Fogaça Jordão

Underexpression Of The Tumor Supressor miR-145 In Patients With Cholangiocarcinoma

ALAG 2021 - XVIII Latin American Congress of Genetics
2021 | Conference poster
Source: Self-asserted source
Pedro Henrique Fogaça Jordão
How many people are using ORCID?